IT
Intra-Cellular
ITCI·NASDAQNew York NYFounded 20021,100 employees
Large CapbiotechPublicCNS
Platform: Lumateperone
Market Cap
$12B
All Drugs
5
Clinical Trials
9
Failed / Terminated
2
FDA Approved
1
Stock Price & Catalysts (ITCI)
Loading ITCI stock data...
Drug Pipeline (5 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Zanufutibatinib | ITC-3831 | NDA/BLA | 1 | CD38 | FabryRB | ||
| ITC-1028 | ITC-1028 | Phase 2 | 1 | BCMA | FLHCC | ||
| ITC-6153 | ITC-6153 | Phase 3 | 1 | KRASG12C | ObesityUrothelial Ca | ||
| ITC-879 | ITC-879 | Approved | 2 | FcRn | Bladder Ca | ||
| Capifutibatinib | ITC-9785 | Phase 3 | 4 | GIP-R | MelanomaRB |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (9)